Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 64

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 64
---
2025. Equity Compensation Plan Information The following table sets forth certain information regarding our equity compensation plans as of March 31, 2025.

| Plan Category                                              | Number ofSecuritiesto BeIssued UponExercise ofOutstandingOptions,Warrantsand Rights(A) |    | Weighted-AverageExercisePrice ofOutstandingOptions,Warrantsand Rights(B) |    | Number ofSecuritiesRemainingAvailable ForFuture IssuanceUnder EquityCompensationPlans (ExcludingSecuritiesReflected InColumn (A))(C) |       |
| Equity compensation plans approved by security holders(1)  |                                                                              1,231,873 | -2 |                                                                   $52.22 | -3 |                                                                                                                            1,589,896 | -4)(5 |
| Equity compensation plans not approved by security holders |                                                                                      — |    |                                                                        — |    |                                                                                                                                    — |       |
| Total                                                      |                                                                              1,231,873 |    |                                                                   $52.22 |    |                                                                                                                            1,589,896 |       |

(1) 2020 LTIP replaced the 2005 LTIP upon stockholder approval of the 2020 LTIP on August 4, 2020. No further grants will be made under the 2005 LTIP. (2) Consists of shares issuable pursuant to the exercise of outstanding stock options and the conversion of outstanding restricted stock units and performance stock unit awards (assuming achievement of maximum performance levels). (3) Calculation of the weighted-average exercise price of outstanding awards includes stock options but does not include restricted stock units and performance stock units that convert to shares of common stock for no consideration. (4) All such shares may be issued pursuant to grants of full-value stock awards. (5) All remaining available securities are from the 2020 LTIP.

| Prestige Consumer Healthcare Inc. | 2025 Proxy Statement |     | 73 |

INFORMATION ABOUT THE ANNUAL MEETING

General Information What is this document? This document is the Proxy Statement of Prestige Consumer Healthcare Inc. for the 2025 Annual Meeting of Stockholders to be held at 10:00 a.m., Eastern Daylight Time, on Tuesday, August 5, 2025 at the Company’s offices, 660 White Plains Road, Tarrytown, New York 10591. A proxy card is included. We have tried to make this document simple and easy to understand. The SEC encourages companies to use “plain English,”